On 5 October 2015, Life Science Developments Limited sold its copper project, changed its name and became a life science and biotech investment company and it also appointed Jim Mellon as a non-executive director.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.68 GBX | +5.00% | +12.00% | -11.58% |
22/05 | Powerhouse resolves claim; PCI-PAL wins court case | AN |
20/05 | Bradda reaches settlement agreement over fraudulent payment | AN |
1st Jan change | Capi. | |
---|---|---|
-11.58% | 79.84L | |
+37.95% | 9.18TCr | |
+21.05% | 7.4TCr | |
-.--% | 2.87TCr | |
+63.04% | 1.06TCr | |
+17.65% | 953.59Cr | |
+23.27% | 910.8Cr | |
+2.81% | 791.31Cr | |
+37.84% | 647.05Cr | |
+20.63% | 507.76Cr |
- Stock Market
- Equities
- CDC Stock
- News Bradda Head Lithium Limited
- Life Science Developments Limited Appoints Jim Mellon as a Non-Executive Director